BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11521523)

  • 1. [Lupus nephritis in the middle of the 20th century and in the beginning of 21st century].
    Tareeva IE; Shilov EM; Krasnova TN; Kozlovskaia LV; Shvetsov MIu; Ianushkevich TN; Samokishina NA
    Ter Arkh; 2001; 73(6):5-10. PubMed ID: 11521523
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasmapheresis in a case of necessary discontinuation of cyclophosphamide in the treatment of severe lupus nephritis].
    Saracyn M; Korsak J; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):162-4. PubMed ID: 15603328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic lupus erythematosus and end-stage chronic renal insufficiency. Therapeutic perspectives].
    Font J; Campistol JM
    Med Clin (Barc); 1989 Apr; 92(15):573-6. PubMed ID: 2666771
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of proliferative lupus nephritis: a changing landscape.
    Adu D
    Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasmapheresis combined with pharmacology in the treatment of lupus nephritis: a new therapeutic protocol].
    Russo GE; Bonello M; Vitaliano E; Bosco M; Maresca L; De Paola A; Tedaldi M; Bisciglia MF; Bauco B
    Clin Ter; 2000; 151(1):9-13. PubMed ID: 10822875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of IGA nephritis].
    Risler T; Braun N
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):996. PubMed ID: 11004910
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of autoimmune hepatitis].
    Rambusch EG; Manns MP
    Dtsch Med Wochenschr; 1996 Dec; 121(49):1539-42. PubMed ID: 8998922
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of systemic lupus erythematosus].
    Ivanova MM
    Klin Med (Mosk); 1985 Jan; 63(1):16-23. PubMed ID: 3887016
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of lupus nephritis in children].
    Niaudet P
    Arch Pediatr; 1999 Dec; 6(12):1312-21. PubMed ID: 10627904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective multicentre trial on the short-term effects of plasma exchange versus cytotoxic drugs in steroid-resistant lupus nephritis.
    Derksen RH; Hené RJ; Kallenberg CG; Valentijn RM; Kater L
    Neth J Med; 1988 Oct; 33(3-4):168-77. PubMed ID: 3067098
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of idiopathic pulmonary fibrosis].
    Dury S
    Rev Mal Respir; 2006 Apr; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517
    [No Abstract]   [Full Text] [Related]  

  • 13. Lupus nephritis: classification, clinical features, and treatment.
    Weissleder R; Galarza DA; Garza MA
    Rev Invest Clin; 1987; 39(3):263-76. PubMed ID: 3324251
    [No Abstract]   [Full Text] [Related]  

  • 14. How did cyclophosphamide become the drug of choice for lupus nephritis?
    Bargman JM
    Nephrol Dial Transplant; 2009 Feb; 24(2):381-4. PubMed ID: 19056783
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressive therapy.
    Katz P
    Am Fam Physician; 1983 Dec; 28(6):172-9. PubMed ID: 6650334
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of lupus nephritis.
    Steinberg AD
    Kidney Int; 1986 Nov; 30(5):769-87. PubMed ID: 3537464
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lupus nephropathy--therapeutic options 1996].
    Matuszkiewicz-Rowińska J; Ostrowski K
    Pol Arch Med Wewn; 1997 Jan; 97(1):85-90. PubMed ID: 9235559
    [No Abstract]   [Full Text] [Related]  

  • 18. [Idiopathic pulmonary fibrosis. II. Treatment].
    Lode H; Erbes R; Raffenberg M
    Dtsch Med Wochenschr; 2001 Apr; 126(14):399-401. PubMed ID: 11332243
    [No Abstract]   [Full Text] [Related]  

  • 19. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus--immunoregulatory therapies.
    Miller ML; Steinberg AD
    Clin Rheum Dis; 1983 Dec; 9(3):617-28. PubMed ID: 6360516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.